Bing-Hua Jiang

Affiliations: 
West Virginia University, Morgantown, WV, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Google:
"Bing-Hua Jiang"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ge X, Li M, Song GX, et al. (2022) Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression. Clinical and Translational Medicine. 12: e1136
Zhang Y, Qiu JG, Jia XY, et al. (2022) METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance. Cancer Letters. 215971
Stieg DC, Wang Y, Liu LZ, et al. (2022) ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance. International Journal of Molecular Sciences. 23
Zhao L, Wang YF, Liu J, et al. (2022) Human endothelial cells promote arsenic-transformed lung epithelial cells to induce tumor growth and angiogenesis through interleukin-8 induction. Aging. 14: 2113-2130
Liu WJ, Huang YX, Wang W, et al. (2021) NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells. Cells. 10
Wang L, Ji XB, Wang LH, et al. (2020) Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer. Frontiers in Cell and Developmental Biology. 8: 840
Wang L, Lu YF, Wang CS, et al. (2020) HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth. Frontiers in Oncology. 10: 1019
Wang L, Ji X, Wang L, et al. (2020) Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer Frontiers in Cell and Developmental Biology. 8
Li W, Wang L, Ji XB, et al. (2019) MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings. Frontiers in Oncology. 9: 1071
Qiu JG, Wang L, Liu WJ, et al. (2019) Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis. Frontiers in Pharmacology. 10: 1002
See more...